Accelerate Drug Development with AI and Open Source

Appsilon builds data and analytics platforms for the pharmaceutical industry, with work spanning clinical trials, pharmacovigilance, and Data Monitoring Committee (DMC) insight and decision support. Eight of the ten largest pharmaceutical companies use its services, and the work centers on Statistical Computing Environments (SCEs) that must hold up under GxP compliance rather than general-purpose dashboarding.

The technical core is validated SCEs built on R and Python, including R package validation work such as Axon.R, paired with Shiny applications for both R and Python. Appsilon also handles migration to open source for teams moving off legacy statistical software, builds custom infrastructure to support these environments, and applies LLM-supported development alongside advanced data visualization for pharma-specific use cases. Artificial intelligence work sits alongside this infrastructure, aimed at the same regulated, evidence-heavy processes rather than replacing them.

Appsilon delivers open source clinical data apps in weeks rather than months and positions GxP-ready platforms as its focus rather than a compliance add-on. The agency is also a creator and contributor to open-source frameworks used in this space, including Rhino, aNCA, and teal, extending its work beyond client delivery into tooling the pharmaceutical R community relies on. Between the validated SCEs, R package validation practice, and GxP-ready platform work, the pattern is a shop built around the compliance and audit demands of pharma analytics.